Rohto Pharmaceutical Co. revenue for the last year amounted to 1.79 B USD, the most of which — 1.17 B USD — came from its highest performing source at the moment, Skin Care, the year earlier bringing 1.18 B USD. The greatest contribution to the revenue figure was made by Japan — last year it brought Rohto Pharmaceutical Co. 1.04 B USD, and the year before that — 1.03 B USD.